Influenza Rx in Practice: Which Antiviral Makes Sense?
Influenza B is the diagnosis and the patient wants to start antiviral therapy. Factoring in CDC guidance, patient preference, and price, which of the 4 options makes most sense?
Daily Dose: Oral Menopausal Hormone Therapy Associated with Higher Risk of NAFLD
Your daily dose of the clinical news you may have missed.
In Older Adults with T2D, Clinical Decision Support Tool Can Reduce Hypoglycemia
In adults older than age 65 years with T2D, a simple clinical decision support tool plus shared decision making reduced hypoglycemic episodes by half.
Primary Care Follow-Up After Emergency Surgery May Help Prevent Readmissions, Improve Patient Outcomes
Results from a new study of Medicare beneficiaries admitted for an emergency general surgery show the odds of 30-day readmission was 67% lower for those with follow-up visit.
Daily Dose: Waist-to-Hip Ratio Better Predictor for Mortality than BMI?
FDA Adds New Warnings to Labeling for Ozempic
The addition of ileus as a potential adverse event associated with the GLP-1 mimetic is not the first required for the class by the regulator.
Pediatric EoE: FDA Accepts Dupilumab sBLA for Priority Review in Children Younger than 12 Years
Dupilumab, a monoclonal antibody targeting type 2 inflammation, would be the first treatment of its kind for younger children with eosinophilic esophagitis.
When the Patient Says Pain is the Problem, Physiatry Has a Plan
The goal of a PM&R physician is to identify the source of function-limiting pain and then develop the best plan for each patient to return them to their lives.
One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults
The prevalence of cardiac, renal, and metabolic conditions has significantly increased over 20 years and so has the number of US adults who have all 3.
Obesity Expert to Primary Care Clinicians: Keep Learning and Know When to Prescribe Antiobesity Drugs
Sandra Christensen, MSN, ARNP, gives her top strategies on patient selection for treatment with antiobesity medications and how to choose the right drugs for patients.
Daily Dose: Long-COVID Rehabilitation Interventions
New COVID-19 Monovalent Vaccine Could Face Resistance, KFF Poll Finds
Less than one-quarter of US adults surveyed said they would "definitely" get the shot while 33% stated they would "definitely not" get the new vaccine.
A Pediatric Rehabilitation Physician's View on Poverty as Cause and Consequence of Disability
Amy Houtrow, MD, PhD, MPH, considers the impact of poverty on childhood disability and talks about opportunities to breach barriers to health care access.
Adding 3000 Ordinary Steps/Day Reduced BP in Sedentary Older Adults with Hypertension
An e-health lifestyle walking intervention partially supported by remote coaching led to significant improvement in BP in older adults as well as a desire to keep walking.
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
Etripamil 70 mg nasal spray restored heart rate within 30 minutes in approximately 60% of PSVT episodes, report authors of new study.
10 Questions on Adult Blood Pressure Targets Based on AAFP Guidelines
The 2022 AAFP Clinical Practice Guideline on hypertension treatment in adults is the subject matter for this 10-question topline quiz that is also a good source of review.
Daily Dose: Fatigue More Common in Chronic vs Episodic Migraine
Oral vs Transdermal Hormone Therapy after Menopause Linked to Increased Risk of NAFLD
Among postmenopausal women taking hormones orally, the NAFLD prevalence increased from 25.3 to 29.4% while it decreased from 24 to 17.3% in those using the transdermal route.
Children with Disabilities Can Grow, Thrive, and Be Part of their Communities: Expert Perspective
Renowned pediatric rehabilitation physician Amy Houtrow, MD, PhD, MPH, highlights the scope of the specialty and its core objectives.
Pegozafermin Receives Breakthrough Therapy Designation for Nonalcoholic Steatohepatitis
The US Food and Drug Administration granted BTD to pegozafermin for the treatment of patients with NASH.